High Purity Afatinib API: Targeted Treatment for Non-Small Cell Lung Cancer
Discover Afatinib, a potent tyrosine kinase inhibitor (TKI) revolutionizing lung cancer therapy. As a premier pharmaceutical intermediate manufacturer in China, we supply high-quality Afatinib API, crucial for your drug formulation needs. Get a competitive quote and samples today.
Get a Quote & SampleLeading Supplier for High-Quality Afatinib API
Afatinib Powder
We are a trusted manufacturer and supplier of Afatinib API, offering high purity (>99%) white crystalline powder. Our commitment to quality ensures your formulations meet stringent pharmaceutical standards. Explore bulk purchase options and inquire about our competitive prices for this essential pharmaceutical intermediate in China.
- Source High Purity Afatinib API: Ensure efficacy with our >99% pure Afatinib powder, a key component for advanced lung cancer treatments.
- Reliable Pharmaceutical Intermediate Supplier: Partner with a manufacturer committed to consistent quality and supply chain stability.
- EGFR Targeted Therapy Excellence: Leverage our Afatinib for effective treatment of EGFR-positive non-small cell lung cancer.
- API Purchase with Confidence: Buy Afatinib API with confidence, backed by GMP, HSE, and ISO 9001 certifications from our China-based facility.
Advantages of Partnering with Us for Afatinib API
Exceptional Purity & Quality
Our Afatinib API consistently meets a purity level exceeding 99%, verified through HPLC and UV testing, ensuring optimal performance in your pharmaceutical formulations. We are a leading supplier for discerning buyers.
Certifications & Compliance
Gain peace of mind with our GMP, HSE, ISO 9001, USP, and BP certifications. As a reputable manufacturer, we guarantee compliance and product integrity for your critical drug development.
Robust Supply Chain & OEM Services
Benefit from our stable production capacity (200kg/Month) and flexible OEM services. We ensure timely delivery and offer customized solutions to meet your specific project requirements as your trusted supplier.
Afatinib: Key Applications in Oncology
Non-Small Cell Lung Cancer (NSCLC) Treatment
Afatinib is a critical API for treating specific types of NSCLC, particularly those that are EGFR-positive, offering a targeted approach for improved patient outcomes.
EGFR Tyrosine Kinase Inhibition
This API functions by blocking epidermal growth factor receptor (EGFR) proteins, inhibiting cancer cell growth and proliferation. Purchase this vital EGFR inhibitor from a reliable manufacturer.
Potential in Other Cancer Therapies
Emerging research suggests Afatinib's potential in other cancer types, making it a valuable pharmaceutical intermediate for ongoing R&D. Inquire about bulk purchase options.
Pharmaceutical Formulation Ingredient
As a high-quality API, Afatinib is essential for pharmaceutical companies developing advanced cancer therapeutics. Find your reliable supplier in China for this critical ingredient.